Substituted piperazines as BTK inhibitors
US12173008B2 · kind B2 · utility
0Cited by
1References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 2023 |
| Grant date | Dec 24, 2024 |
| Priority date | — |
| Expiry date | Apr 17, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to heteroaryl heterocyclic compounds of formula (I), pharmaceutical compositions comprising same, methods for preparing same, and uses thereof, wherein the variables are as defined in the description.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.